Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 145

Sort by

Sort Order Select

Journal Articles

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events

Stefan Schmidt, Dimitri Daniliants, Elisabeth Hiller, Eberhard Gunsilius, Dominik Wolf, Clemens Feistritzer

Blood Adv (2021) 5 (18): 3515–3527.

https://doi.org/10.1182/bloodadvances.2020004061

Published: 2021

Includes: Supplemental data

Journal Articles

Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation

Rima M. Saliba, Uri Greenbaum, Qing Ma, Samer A. Srour, Yudith Carmazzi, Liang Li, Betul Oran, Michael Moller, Janet Wood, Stefan O. Ciurea, Piyanuch Kongtim, Gabriela Rondon, David Partlow, Dan Li, Katayoun Rezvani, Elizabeth J. Shpall, Kai Cao, Richard E. Champlin, Jun Zou

Blood Adv (2021) 5 (17): 3407–3417.

https://doi.org/10.1182/bloodadvances.2021004307

Published: 2021

Includes: Supplemental data

Journal Articles

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Stéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, Anne-Claire Mamez, Stavroula Masouridi-Levrat, Dominik Heim, Jörg Halter, Gayathri Nair, Yves Chalandon, Urs Schanz, Tayfun Güngör, Grazia Nicoloso, Jakob R. Passweg, Jean Villard, on behalf of the Swiss Blood Stem Cell Transplantation Group

Blood Adv (2021) 5 (17): 3377–3386.

https://doi.org/10.1182/bloodadvances.2020003998

Published: 2021

Includes: Supplemental data

Journal Articles

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Blood Adv (2021) 5 (17): 3309–3321.

https://doi.org/10.1182/bloodadvances.2021004456

Published: 2021

Includes: Supplemental data

Journal Articles

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Blood Adv (2021) 5 (17): 3290–3302.

https://doi.org/10.1182/bloodadvances.2020003669

Published: 2021

Includes: Supplemental data

Journal Articles

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Monzr M. Al Malki, Ni-Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine Zain, Samer Khaled, Anthony Stein, David Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura

Blood Adv (2021) 5 (12): 2650–2659.

https://doi.org/10.1182/bloodadvances.2021004192

Published: 2021

Includes: Supplemental data

Journal Articles

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Toshihito Hirai, Po-Yu Lin, Federico Simonetta, Kristina Maas-Bauer, Mustafa Turkoz, Melissa Mavers, Jeanette Baker, Robert S. Negrin

Blood Adv (2021) 5 (11): 2528–2538.

https://doi.org/10.1182/bloodadvances.2020003272

Published: 2021

Includes: Supplemental data

Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk

Blood Adv (2021) 5 (8): 2196–2215.

https://doi.org/10.1182/bloodadvances.2020003805

Published: 2021

Includes: Supplemental data

Journal Articles

Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML

Brian C. Shaffer, Jean-Benoit Le Luduec, Soo Park, Sean Devlin, Anne Archer, Eric Davis, Candice Cooper, Melissa Nhaissi, Beth Suri, Deborah Wells, Roni Tamari, Esperanza Papadopoulos, Ann A. Jakubowski, Sergio Giralt, Katharine C. Hsu

Blood Adv (2021) 5 (7): 2003–2011.

https://doi.org/10.1182/bloodadvances.2020002701

Published: 2021

Includes: Supplemental data

Journal Articles

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Margaret L. MacMillan, Keli L. Hippen, David H. McKenna, Diane Kadidlo, Darin Sumstad, Todd E. DeFor, Claudio G. Brunstein, Shernan G. Holtan, Jeffrey S. Miller, Erica D. Warlick, Daniel J. Weisdorf, John E. Wagner, Bruce R. Blazar

Blood Adv (2021) 5 (5): 1425–1436.

https://doi.org/10.1182/bloodadvances.2020003219

Published: 2021

Includes: Supplemental data

Journal Articles

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Amy E. DeZern, Clio Franklin, Hua-Ling Tsai, Phil Hollingsworth Imus, Kenneth R. Cooke, Ravi Varadhan, Richard J. Jones

Blood Adv (2021) 5 (5): 1360–1368.

https://doi.org/10.1182/bloodadvances.2020003922

Published: 2021

Includes: Supplemental data

Journal Articles

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor, Judith Witte, Mukta Arora, Jo-Anne Young, Daniel J. Weisdorf

Blood Adv (2021) 5 (5): 1352–1359.

https://doi.org/10.1182/bloodadvances.2020003937

Published: 2021

Includes: Supplemental data

Journal Articles

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Luisa Strocchio, Daria Pagliara, Mattia Algeri, Giuseppina Li Pira, Francesca Rossi, Valentina Bertaina, Giovanna Leone, Rita Maria Pinto, Marco Andreani, Emanuele Agolini, Katia Girardi, Stefania Gaspari, Lavinia Grapulin, Francesca del Bufalo, Antonio Novelli, Pietro Merli, Franco Locatelli

Blood Adv (2021) 5 (5): 1333–1339.

https://doi.org/10.1182/bloodadvances.2020003707

Published: 2021

Journal Articles

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

Blood Adv (2021) 5 (5): 1199–1208.

https://doi.org/10.1182/bloodadvances.2020003739

Published: 2021

Includes: Supplemental data

Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Blood Adv (2021) 5 (5): 1154–1163.

https://doi.org/10.1182/bloodadvances.2020003779

Published: 2021

Journal Articles

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Zachary Davis, Martin Felices, Todd Lenvik, Sujan Badal, Joshua T. Walker, Peter Hinderlie, James L. Riley, Daniel A. Vallera, Bruce R. Blazar, Jeffrey S. Miller

Blood Adv (2021) 5 (4): 1069–1080.

https://doi.org/10.1182/bloodadvances.2019001110

Published: 2021

Includes: Supplemental data

Journal Articles

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors

Blood Adv (2021) 5 (4): 975–983.

https://doi.org/10.1182/bloodadvances.2020003654

Published: 2021

Journal Articles

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

Suhag Parikh, Joel A. Brochstein, Einat Galamidi, Aurélie Schwarzbach, Joanne Kurtzberg

Blood Adv (2021) 5 (3): 843–852.

https://doi.org/10.1182/bloodadvances.2020003248

Published: 2021

Includes: Supplemental data

Journal Articles

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience

Katie Maurer, Anna Saucier, Haesook T. Kim, Utkarsh Acharya, Clifton C. Mo, Julie Porter, Cindy Albert, Corey Cutler, Joseph H. Antin, John Koreth, Mahasweta Gooptu, Rizwan Romee, Catherine J. Wu, Robert J. Soiffer, Sarah Nikiforow, Caron Jacobson, Vincent T. Ho

Blood Adv (2021) 5 (3): 861–871.

https://doi.org/10.1182/bloodadvances.2020003883

Published: 2021

Includes: Supplemental data

Journal Articles

Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions

Sarah J. Waldis, Stacey Uter, Donna Kavitsky, Cynthia Flickinger, Sunitha Vege, David F. Friedman, Connie M. Westhoff, Stella T. Chou

Blood Adv (2021) 5 (3): 737–744.

https://doi.org/10.1182/bloodadvances.2020003732

Published: 2021

Includes: Supplemental data

NARROW

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events

Mismatch in SIRPα, a regulatory protein in innate immunity, is associated with chronic GVHD in hematopoietic stem cell transplantation

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted

Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipients

Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant

Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Prospective KIR genotype evaluation of hematopoietic cell donors is feasible with potential to benefit patients with AML

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Steroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes

HLA-haploidentical TCRαβ + /CD19 + -depleted stem cell transplantation in children and young adults with Fanconi anemia

Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors

Allogeneic stem cell transplantation with omidubicel in sickle cell disease

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience

Rh alloimmunization in chronically transfused patients with thalassemia receiving RhD, C, E, and K matched transfusions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only